Product Description: K-756 is a direct and selective tankyrase (TNKS) inhibitor, which inhibits the ADP-ribosylation activity of TNKS1 and TNKS2 with IC50s of 31 and 36 nM, respectively.
Applications: Cancer-programmed cell death
Formula: C24H27N5O3
References: [1]Okada-Iwasaki R, et al. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Mol Cancer Ther. 2016 Jul;15(7):1525-34.
CAS Number: 130017-40-2
Molecular Weight: 433.50
Compound Purity: 99.25
Research Area: Cancer
Solubility: DMSO : 4.55 mg/mL (ultrasonic)
Target: PARP